Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02325479Phase 1Completed
Phase 1, randomised, double-blind trial of enoxaparin in infertility, sponsored by Egyptian IVF-ET Center. Primary endpoint: Pregnancy Rate at 14 days. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02325479.